AstraZeneca Hit With New Compliance Mandates In Seroquel Settlement With States
This article was originally published in The Pink Sheet Daily
Executive Summary
A $68.5 million settlement agreement with the states imposes restrictions on physician detailing and the presentation of clinical trial data, among other things.